The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Insulin and epidermal signals independently shape sexually dimorphic neurite branching in C. elegans
Sexual state-regulated insulin signaling and vulval epithelial cues engage distinct pathways to remodel the F-actin ...
OBJECTIVE: The aim of this study was to assess the immunohistochemical expression of second-generation neuroendocrine markers such as insulin gene enhancer protein 1, insulinoma-associated protein 1, ...
At the forum “Gene editing in agriculture - Strategic technology tied to a legal framework” held on October 18, Deputy Minister of Agriculture and Environment Phung Duc Tien emphasized that ...
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using ‘longevity genes’ found in people who live exceptionally long lives - over 100 years old.
Abstract: In genome-scale constraint-based metabolic models, gene deletion strategies are crucial for achieving growth-coupled production, where cell growth and target metabolite production are ...
As fears swirl about artificial intelligence upending Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google's dominance in search, Deepwater Asset Management's Gene Munster says the company is sending ...
Gene Munster, Deepwater Asset Management managing partner, joins 'The Exchange' to discuss why equity markets aren't in a bubble, the OpenAI-Broadcom deal and much more. Donald Trump says Republican ...
In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...
ABB has signed a term sheet agreement with SwitcH2 to engineer and supply automation and electrification solutions for SwitcH2’s floating production, storage and offloading (FPSO) unit dedicated to ...
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback